Clinical Trial Update: A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating melphalan with or without siltuximab for multiple myeloma patients undergoing autologous stem cell transplant. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)
• Siltuximab (siltuximab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma | Phase 2 | Status: RECRUITING